In a study by Perez-Alvarez et al. [66], 257 patients were analyzed—89 carriers of HBsAg and 168 hidden carriers (anti-HBc+) treated with anti-TNF-α due to rheumatoid arthritis or inflammatory bowel diseases. This evidence concerns the gene TNF and rheumatoid arthritis.